The monoclonal antibodies in veterinary health market face growth opportunities due to rising animal chronic diseases and pet ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...

New OHSU study maps antibody "hot spots" behind anti‑NMDAR encephalitis. Could change diagnosis and treatment.

America has an Alzheimer’s problem, devastating families and driving soaring healthcare costs. More than 7 million people over 65 years old live with Alzheimer’s dementia today, a number predicted to ...

Live Action alleges "reckless distribution" of the abortion drug mifepristone, urging the Trump administration to suspend its ...

Due to the “programmable” nature of the nanoparticle, researchers are able to “swap out the antibodies or the drugs to target different diseases — like autoimmune disorders or different types of ...

The singer offered fans a glimpse at one of her health secrets.

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

TOKYO -- The leader of Japanese opposition party Reiwa Shinsengumi, Taro Yamamoto, 51, announced on the party's YouTube ...